Summary: A procedure for the determination of senim high-density lipoprotein choline-containing phospholipids is described. The choline-containing phospholipids represent 91-97% of the total serum and high-density lipoprotein phospholipids, which have previously been determined in relation to liver disease, neoplastic disorders, diabetes rnellitus and atherosclerosis. The eiizymatic ässay is quick, simple and precise. No interference was found from the precipitating agents used to isolate the high-density lipoprotein fraction. Several serum samples were assayed for high-density lipoprotein cholesterol and choline-containing phospholipids. From this preliminary data there would appear to be a correlation between these two lipid classes.
Introduction
The determination öf total serum phospholipids has previpusly been performed in thestudy pf .several disease states, primaiüy for research purpöses. They are usually detennined by chemicäl digestion of the organic portipn pf the phospholipids followed by phpsphate determination. Total serum phospholipids have beeil measured in relation to extrahepatic obstruction (1), certain neoplastic disorders (2) , diabetes mellitus (3) and atherosclerosis (3, 4) .
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The determination of serum high-density lipoprotein (HDL) chplesterol has become a widely used test for ässessülg the predispositioh to coronary heart disease since HDL cholesterol levels have been shown to be inversely related to the risk of developing coronary heart disease (5) . There may also be a relationship between serum HDL-choline-containing phospholipids and the risk of developing coronary heart disease, due to the role of phospholipids in lipoproteins. Phospholipids have been reported to stabilize lipoproteins and may be necessary for the binding of cholesterol and its esteirs to the lipoproteins (6, 7) .
A method for the determination of total serum cholinecontaining phospholipids has been previously described 0340-076X/82/0020-0807$02.00 (8) . This procedure utilized phospholipase D from Streptomyces chromofuscus to hydrolyze choline from phosphatidylcholine, lysophosphatidylcholine and sphingomyelin. It is of note that not all phospholipids contain choline. However, those that do comprise 91-97% of the total phospholipids found in serum (9, 10) . Choline oxidase was theri used to generate hydrogen peroxide from the choline, and the hydrogen peroxide was in turn utilized in the peroxidase catalyzed oxidative coupling of 4-aminoantipyrine and phenol to form ared quinonimine chromogen. This procedure has since been applied to the determination of HDL choline-containing phospholipids (3, (11) (12) (13) . Since the amount of choline-containing phospholipids in the serum HDL fraction is typically only 48% of the total serum cholinecontaining phospholipids (9) the original proced re was modified to increase its sensitivity by the Substitution of sodium 2-hydroxy-3,5-dichlorobenzenesulfonate for phenol in the peroxidase-catalyzed indicator reaction. This type of modification has been used previously in procedures for the determination of HDL cholesterol (14) and choline-containing phospholipids in amniotic fluid (15) . The use of 2-hydroxy-3,5-dichlorobenzenesulfonate has been shown to produce a several-fold increase in sensitivity over that of phenol (14) thus, facilitating a marked improvement in the sensitivity and precision of lipid determinations.
In the present report the characteristics of this procedure are described including the possible interfering effects of the precipitating reagents that were used previously in an HDL cholesterol procedure (14) . This precipitating reagent has previously been compared with several other precipitating agents for possible interfering effects in an enzymatic HDL cholesterol assay (16) . Finally, this procedure for HDL choline-containing phospholipids is used iri a preliminary investigation into the possible correlation between serum HDL cholesterol and HDL choline-containing phospholipids. To this end, several serum samples, ranging widely in total cholesterol concentrations, were assayed for both HDL cholesterol and choline-containing phospholipids and the degree, of correlation between them was determined. Lecithin Standards: Ζ,-α-phosphatidylcholine (dipalmitoyl, sym thetic) was dissolved in deionized water, cpntainiiig 5 g/l Triton X-100j to a concentration of 3.0 mmol/l. Serial dilutions qf this Standard were made with 5 g/l Triton X-100 to contain 0.5,1.0, 1.5 and 2:0 irimpl/l lecithin. Cholesterol reagent: Prepare this reagent by reconstitution of the previPusly described dry ehzyme reagent (14) with deiPriized water containing 4-aniinoantipyrine and Vhydroxy-3,5-dichlorobenzeriesulfonate to final concentrations of 2.4 and 9 mmol/l, respectively. Magnesium acetate: Prepare this reagent to contain 2 mol/1 magnesium acetate in deionized water. Dextran sulfate 500: Prepare this re gent to contain 20 g/l dextran sulfate 500 in deionized water. All enzyfne units quoted are used s defiried by the sappliers.
Materials and Methods

Procedures
Isolation of serum HDL fractions · To l ml of serum add 50 μΐ of dextran sulfate 500 solution arid mix well. Subsequently 50 μΐ of magnesium acetate solutiPn was added arid mixed well. This mixt re was theri allowed to stand at room temperature for 10 min followed by centrifugation at 1200 g for 15 min. After centrifugation the HDL-containing supernatant was transferred to a clean tube (18) . Note that this prPcedure may be scaled down considerably.
Determination of choline-containing phospholipids ,
The working phospholipid reagent was dispensed iftt l ml liquot$ and incubated at 37 °C, for 3 min.,Upon completion of this preincubation 100 μΐ of the sodium 2-; hydrpxy^3,5-dichlorobenzenesulfonate reagent was added and mixed. It is possible to premix the 2-hydroxyrS^-dichlofobenzenesulfon^te and phospholipid reagents, however, the absorbance of the blank may increase significantly pVer the jperipd of 1-3 d ys. Consequently we ehose to separate them in order to improve thfe shelf life of the reagents (i.e., prevent the air catalyzed oxidative eoupling of the chromogen System). Ten microliters of sample or Standard were added, mixed and incubated at 37 P C for 12 min. After incubation the absprbance was measured at 510 nm against a reagent blank, in which deionized water wa$ substituted f r sample or Standard.
.
Determination of cholesterol Ten rnicroliters of sample or Standard were added and mixed with l ml of the cholesterol reagent. After a 10 min incubation at 37 °C, the absorbance was measured at 510 nm against a reagent blank in which deionized water was substituted for the sample (14) . The values obtained for HOL choline-containing phospholipids and HDL cholesterol were multiplied by 1.1 to correct for the dilution of sample due to the addition of the precipitating reagents.
Results and Discussion
Preliminary experiments were conducted in order to optimize the activities of the erizymes and the sample to reagent ratio for the choline-containing phospholipids procedure. Under the described reaction conditions the hydrolysis of the phospholipids, the oxidation of the choline and the coupling of the indicator reaction are complete within 10-15 min for the phospholipid concentrations commonly encountered in the HDL fraction of serum. As described, a 12 min incubation was used routinely with fresh feageat. However, it was found to be necessary to extend this incubation to 15 min for working phospholipid reagent that was 3 days old.
Apart from the necessity of using a slightly longer incubation in order to reach equilibrium there were no apparent deleterious effects resülting from the use of 3 day old working phospholipid reagent. The time required to reach equilibrium may be checked by plotting a rise curve, äs described in figure l, using the high Standard äs a sample. It may be seen in figure l that equilibrium over the rarige of 1.0-3.0 mmol/1 is reaehed within 15 min. The use of calcium äs an activator for phospholipase D of microbial origin has been described previously (19) . Although it has been reported (l 5) that it was not necessary to include calcium in the reagent, subsequent studies indicate that it is a rjecessary ingredient. Figure 2 depicts a plot of calcium concentration versus the rate of colour development for the assay. It may be seen that the activity increases markedly up to a calcium concentration of 0.1 mmol/1 and then remains relatively constant to 1.0 mmol/1. In order to allow considerable latitude in reagent preparation, 0.5 mmol/1 calcium was chosen to be optimal. As has been described previously Triton X-100 is inchided in the reagent äs a sqlubilizer of reagents and samples (15) äs well äs an activator of microbial phospholipase D (19) .
Unlike the phospholipase D from cabbage which shows activity primarily towards phosphatidylcholine, the phospholipase D of microbial origin exhibits activity towards other phospholipids such äs phosphatidylethanolamine äs well äs the other choline-containing phospholipids, lysophqsphatidylcholine and sphingomyelin (15, 19) . However, since choline oxidase is specific for choline and the intermediate betaine aldehyde (20) , only the choline-containing phospholipids are measured in this procedure. Measuring only the cholirle-containirig phospholipids still gives an accurate representation of the overall phospholipid level in serum, äs the choline-containing phospholipids typically comprise something greater than 91% of the total serum phqspholipids (9, 10) . It is also of note that the cholinecontaining phospholipid content of the HDL fraction is sirnilar to that of whole serum (9) .
The concentration of choline-containing phospholipids in this report is expressed in units of mmol/1 rather than mg/dl due to the heterogeneity of the phospholipids. Phosphatidylcholine, lysophosphatidylcholine and sphingomyelin differ from each other in their basic structures äs well äs within their separate classes with regard to the degree of Saturation and length of their fatty acid chain(s) (9) . It would seem to follow that the choline-containing phospholipid concentration of serum should not be readily compared to the concentration of a homogeneous Standard on a weight per unit volume basis. By using a synthetic phosphatidylcholine whose molecular weight is known, it is possible to relate the absorbance obtained to the number of moles of choline released, and therefore to the number of moles of choline-containing phospholipid in the sample. In a previous report (14) , the Substitution of 2-hyd Oxy-3,5-dichlo obenzenesulfonate for phenol in an enzymatic HOL cholesterol procedure was described. The Substitution resulted in a 4.4 fold increase in sensitivity äs well äs an increase in the precision of the procedure. The enzymatic determination of choline-containing phospholipids is already iriherently more sensitive than that of cholesterol, since the choline oxidase catalyzed oxidation of one mole of choline produces two moles of hydrogen peroxide while oxidation of one mole of cholesterol by cholesterol oxidase produces but one mole of hydrogen peroxide. This can be more easily seen in a plot of their respective Standard curves ( fig. 3 ). These curves were obtained with equimplar amounts of choline and cholesterol, using their respective oxidases tp generate hydrogen peroxide. Peroxidase was then used in the oxidative coupling of 4-aminoantipyrine and 2-hydroxy-3,5-dichlorobenzenesulföriate to form the measured chromogen. It may be determined from figure 3 that the slope of the curve for the HOL choline-containing phospholipids assay is nearly twice that of the cholesterol assay, on a molar basis. The increased sensitivity due to the Substitution of 2-hydroxy-3,5-dichlorobenzenesulfonate for phenol has also produced an increase in the precision of the HOL choline-containing phospholipids assay. The precision of the HOL choline-containing phospHolipids assay was checked by assaying several aliquots of varipus serum pools. Oh the basis of the data preserited in table l both the within-run and between-irun reproducibility of the proposed procedüre was judged to be acceptable.
Tab. 1. Reproducibility of the proposed cholinescontäining phospholipid procedüre. The determination of the choline-containing phospholipids in the HDL fräction of serum following chemical precipitatiori of the LDL and VLDL fractipns may be considered to be controversial. Switzer &Eder (21) have reported that lysplecithin comprises 9.6% ofthe total phospholipids of serum and that a major portion of this phospholipid is associated with albumin and thu's would not be precipitated with the LDL and VLDL molecules. Hpwever, in a more recent review (22) no mention of this phenomenon was made but rather it was stated that all of the lipids, apart frorn the free fatty acids, were carried in the plasina äs lipoprotein complexes. As well, recent studies that have compared chemical fräctionatiori to electrophoresis (1) and ultracentrifugation (11, 23) have reipörted good correlation between the techniques and have made np mention of an albumin-lysplecithin complex. More recently, Wille (24) reported that there is an albuitiinapolippprötein A-I complex in serum which is able to bind lysolecithin. This complex has an electrpphpretic mobility similar tp albuinin and appears in the d > l .21 kg/l (VHDL) fraction obtained by ultracentrifugation. Further, this complex is able to bind more lysolecithin than albumin can alpne. Since this complex contains apolipoprotein A-I, which appärently binds most Pf the lysolecithin in the complex,'it seems reasonable to include the lysolecithin of this complex in the determination of HDL choline-containing phospholipids. Therefore, on the basis of this leport, the above mentioned comparative studies (l, 11,23) The combination of rnagnesium acetate and dextran sulfate 500 was chosen äs the precipitating agents for the HOL choline-containing phospholipid assay due to their previous use in the determination of HOL cholesterol (14) . It was shown in this previous report that magnesium/dextran sulfate 500 did not interfere in the enzymatic determination of HOL cholesterol. In a subsequent paper (16) , magnesium/dextran sulfate 500 was compared with magnesium/phosphotungstate, manganese/heparin and polyethylene glycol 6000 for possible interference with the determination of cholesterol and was found not to interfere. Since the HDL choline-containing phospholipid assay involves a different enzymic sequence under different reaction conditions, it seemed necessary to repeat the interference study with the magnesium/dextran sulfate reagents. This was done by comparing the performance of the normal reagent with that of a reagent contaminated with magnesium/dextran sulfate 500. The Contaminated reagent was prepared to contain magnesium/dextran sulfate 500 to the concentration that would be present if 10 of an HDL fraction had been added to l .0 ml of reagent. A series of spectra obtained using the contaminated and the uncontaminated reagents with lecithin Standards are shown in figure 4. Our previous study (16) indicated that the precipitating agents do not cause any measurement problems if the reactions are carried out at 37 °C äs described under procedufe. There appears to be no consistent difference between the spectra obtained with the eontamined reagent and the spectra obtained with the uncontaminated reagent. The spectra are intended to show the lack of any obvious interference due to the magnesium/dextran sulfate. The small difference between contaminated and uncontaminated spectra are probably due to the experimental error, in that repeated studies in which single wavelength measurements at 510 nm were made failed to reveal an interference.
There has been a great interest in the determination of serum HDL cholesterol levels due to its proposed involvement in the atherosclerotic process. The HDL molecule has been postulated to pick up cholesterol from peripheral tissues for transfer to other lipoproteins or for transport to the liver for disposal (25) . This removal of cholesterol is also proposed to involve the enzyme lecithin: cholesterol acyltransferase which is activated by apolipoprotein A-I of the HDL molecule. The esterification of cholesterol by the transfer of a fatty acid from lecithin is catalyzed by lecithin: cholesterol^scyltransferase (25) . However, it is not yet known whether or not this proposed role of HDL is the mechanism for its protective nature. Since at least part of the role of phospholipids in the serum lipoproteins is to allow the lipoproteins to cany the neutral lipids, it would seem to be reasonable that one might expect to find a correlation between HDL cholesterol and HDL cholinercontaining phospholipids. For this reason, and äs a possible application of this method, we obtained 55 serum sämples whose total cholesterol levels ranged from 82 to 437 mg/dl (2.1-11.3 mmol/1) and determined their levels of HDL eholesterol and HDL cholinecontaining phospholipids. A plot of HDL cholesterol vs HDL choline-containing phospholipids is shown in figure 5 . There appears to be a linear relationship be- tween the two, äs evidenced by the coefficient of correlation of 0.913. As well, it may be noted that there is a negative intercept suggesting that there may be measurable amounts of phospholipids present when there is no detectable cholesterol. This preliminary data appears to correlate well with the work of previous investigators (3, 9, (11) (12) (13) 23) . Although comparison of the HOL phospholipid concentrations is difficult, due to the use of units based on a weight per unit volume rather than a moles per liter System, it would appear that our mean value of l .368 mmol/1 HOL choline-containing phospholipid falls in the middle of the apparent ränge of mean values of 0.570-1.834 mmol/1 that we calculated from previous reports (3, 9, (11) (12) (13) 23) . In addition, the good correlation obtained between HOL cholesterol and choline-containing phospholipids, demonstrated in flgure 5 (r -0.913) is consistent with the previous studies of the investigators on this controversial issue (11) (12) (13) 23) . The determination of MDL choline-containing phospholipids may prove to be iuseful in the investigation of the atherosclerotic process. The described procedure would appear to be more convenient than the traditional method (26) and more sensitive and reproducible than the previous enzymic procedure (8, 11) .
